Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-03-14 @ 4:04 AM
Study NCT ID:
NCT03151551
Status:
COMPLETED
Last Update Posted:
2020-11-03
First Post:
2017-05-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-04
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-04
First Submit QC Date:
None
Study First Post Date:
2017-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-02-22
Results First Submit QC Date:
None
Results First Post Date:
2019-04-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-09
Last Update Post Date:
2020-11-03
Last Update Post Date Type:
ACTUAL